Interrelationships in mice of antipyrine half-life, hepatic monooxygenase activities and liver S9-mediated mutagenicity of aflatoxin B1, benzo[a]pyrene 7,8-dihydrodiol, 2-acetylaminofluorene and N-nitrosomorpholine
- 6 November 1983
- journal article
- research article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 47 (2) , 175-194
- https://doi.org/10.1016/0009-2797(83)90156-4
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Carcinogen Metabolism in Human Tissues and CellsDrug Metabolism Reviews, 1982
- Searches for ultimate chemical carcinogens and their reactions with cellular macromoleculesCancer, 1981
- Cytochrome P-450: A pharmacological necessity or a biochemical curiosity?Biochemical Pharmacology, 1981
- Pharmacogenetics: An Approach to Understanding Chemical and Biologic Aspects of CancerJNCI Journal of the National Cancer Institute, 1980
- Metabolism of drugs and carcinogens in man: Antipyrine elimination as an indicatorClinical Pharmacology & Therapeutics, 1979
- Relationship between in vivo and in vitro drug metabolism in manEuropean Journal of Drug Metabolism and Pharmacokinetics, 1978
- Factors influencing antipyrine elimination.British Journal of Clinical Pharmacology, 1977
- Comparative metabolism of benzo[a]pyrene and drugs in human liverClinical Pharmacology & Therapeutics, 1977
- Elimination of antipyrine and benzo[a]pyrene metabolism in cultured human lymphocytesClinical Pharmacology & Therapeutics, 1976
- Increased Clearance of Antipyrine and d-Propranolol after Phenobarbital Treatment in the MonkeyJournal of Clinical Investigation, 1974